fb 777 casino
Texas groups urge lawmakers to fund improvements to fix Medicaid and SNAP delaysAds jar epic documentaryLiverpool leads as the class of the Champions League this season, dumping title holder Real Madrid into an almost unbelievable 24th place in the 36-team standings. No one felt the embarrassment of Madrid’s 2-0 loss at Anfield more than Kylian Mbappé, the superstar added in the offseason by the storied club that also was European champion against Liverpool in the finals of 2022 and 2018. Mbappé had a penalty saved in the second half and was earlier dumped on his behind by Conor Bradley’s perfect tackle in an instant viral moment. Monaco missed a chance to go second in the table, giving up a lead playing with 10 men from the 58th minute in a 3-2 loss at home to Benfica. Swiss forward Zeki Amdouni scored the winning goal in the 88th. Borussia Dortmund, the beaten finalist against Madrid in May, is up to fourth place after beating Dinamo Zagreb 3-0. Champions League standout Jamie Gittens now has four goals in five games, curling a rising shot in the 41st to open the scoring. The best comeback was at PSV Eindhoven, where the home team trailed Shakhtar Donetsk by two goals in the 87th minute before a 3-2 win was sealed by United States forward Ricardo Pepi’s goal deep in stoppage time. US defender Cameron Carter-Vickers scored an embarrassing own goal for Celtic — playing a no-look pass far beyond goalkeeper Kasper Schmeichel — in a 1-1 draw with Club Brugge. Liverpool’s stand-in right back Bradley was a standout Wednesday, playing a key pass that set up Alexis Mac Allister to score the opening goal in the 52nd. After Mbappé’s penalty was pushed away by goalkeeper Caoimhín Kelleher in the 61st, Liverpool star Mo Salah missed with his spot-kick in the 70th, before substitute Cody Gakpo sealed the win with a header in the 77th. Madrid now has lost three of five games after defeats at Lille and at home to AC Milan. The record 15-time European champion has another tough trip next, at fifth-place Atalanta on Dec. 10. Congo teammates Ngal’Ayel Mukau and Silas impressed in wins for Lille and Red Star Belgrade. Mukau scored twice in 12th-place Lille’s 2-1 win at Bologna and Silas leveled for Red Star in a 5-1 rout of Stuttgart, though he barely celebrated his goal. Silas is on loan with the Serbian champion from Stuttgart. Aston Villa drew 0-0 with Juventus. ___ AP soccer: https://apnews.com/hub/soccer Graham Dunbar, The Associated Press
SolarEdge shares fall on new CEO appointmentORLANDO, Fla.--(BUSINESS WIRE)--Dec 18, 2024-- Gilgal Medical Supplies, a leading provider of medical supplies in Florida with locations throughout the state, has announced a strategic change in its operations. Effective immediately, the company will no longer accept insurance for medical supplies. This decision comes after years of increasing challenges and systemic difficulties associated with insurance reimbursement processes. "Providing durable medical equipment and supplies for thousands of patients has always been at the core of our mission," said Thomas Chacko, Vice President at Gilgal Medical Supplies. "However, the constant denials, excessive documentation requests, unnecessary audits, and recoupment efforts by Medicare and insurance companies have made the process untenable." For years, insurance companies have imposed increasingly burdensome requirements, often prioritizing their bottom line over patient care. This has created significant hardships for durable medical equipment providers like Gilgal Medical Supplies, affecting their ability to serve patients effectively. The intense administrative demands and frequent audits have reached a point where continuing to accept insurance is no longer sustainable. Gilgal Medical Supplies has taken measures to ensure its current patients have ample time and support to transition to other providers. "We remain deeply committed to our patients and their well-being," said Thomas Chacko. "We are working diligently to provide them with the necessary resources and guidance during this transition." Moving forward, Gilgal Medical Supplies will focus on retail sales and wholesale distribution. This new direction will allow the company to continue providing high-quality medical supplies without the constraints and inefficiencies of the insurance reimbursement system. "We believe this shift will enable us to serve our customers more effectively and focus on delivering value directly to those who need it," added Thomas Chacko. Gilgal Medical Supplies operates from strategic locations across Florida and we serve thousands of customers a month on a monthly basis. For more information about Gilgal Medical Supplies’ services and offerings, visit www.gilgalmedical.com or call 407 891 2120. About Gilgal Medical Supplies Founded with a mission to serve the medical supply needs of Florida communities, Gilgal Medical Supplies has built a reputation for quality products and exceptional customer service. With a focus on integrity and care, Gilgal remains committed to enhancing lives through reliable and accessible solutions. View source version on businesswire.com : https://www.businesswire.com/news/home/20241218129761/en/ CONTACT: Media Contact: Gilgal Medical Supplies Phone: 407 484 0032 Email:tchacko@gilgalmedical.com KEYWORD: FLORIDA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: SURGERY CHILDREN BABY/MATERNITY OTHER HEALTH SOFTWARE ALTERNATIVE ENERGY HARDWARE ENERGY MEDICAL DEVICES INFECTIOUS DISEASES HOSPITALS TECHNOLOGY CARDIOLOGY WOMEN BIOTECHNOLOGY PRACTICE MANAGEMENT VETERINARY AIDS MANAGED CARE MEDICAL SUPPLIES HEALTH MEN FINANCE FAMILY PROFESSIONAL SERVICES CONSUMER SOURCE: Gilgal Medical Supplies Copyright Business Wire 2024. PUB: 12/18/2024 03:00 PM/DISC: 12/18/2024 03:00 PM http://www.businesswire.com/news/home/20241218129761/en
( ) shares are pushing higher on Friday morning. At the time of writing, the ASX 200 stock is up 2% to $16.76. Why is today a big day for the ASX AI stock? Today is the day that NextDC shareholders gather for its annual general meeting. But ahead of the main event, the data centre operator has released its . In respect to the former, the company spoke extensively about how well it is positioned to benefit from the rise of artificial intelligence. Management described it as "one of the most profound transformations in the history of technology." The ASX 200 AI stock's CEO, Craig Scroggie, said: AI is set to drive one of the most profound transformations in the history of technology, ushering in the Fourth Industrial Revolution. For NEXTDC, this moment is a defining opportunity. We're not only positioned to meet the rising demand for AI but to set the benchmark for innovation, resilience, and sustainable data centre infrastructure. Scroggie also highlights that research shows that the global data centre market is expected to reach $1 trillion by 2030. He adds: Data centres are the backbone of the digital economy. McKinsey forecasts the global data centre market will reach $1 trillion by 2030, highlighting the extraordinary demand for digital infrastructure. Together, we are empowering enterprises to harness the full potential of the digital age—and for NEXTDC, that journey is only just beginning. As we enter a new era defined by AI, our achievements over the past decade are merely the foundation. The momentum surrounding AI signals a transformational chapter for the digital infrastructure industry, one that promises unprecedented growth in the decade ahead. Should you invest? As things stand, there are a number of leading brokers that rate this ASX 200 AI stock as a buy. One of those is Goldman Sachs, which has a buy rating and $18.50 price target on NextDC shares. Commenting on its buy recommendation, the broker said: We are particularly positive on NXT and are Buy rated given the rapid growth in cloud adoption, which has been supported by the continued evolution of the enterprise telecommunications market, and the significant demand by both public and private investors for digital infrastructure assets. We believe the company has a compelling growth profile and a proven and profitable business model, noting it trades on a growth-adjusted discount vs. peers, which we view as unjustified.
Healey: Proscription status of Syria’s new rulers is not a matter for nowWhy today is a big day for this ASX 200 AI stock
SolarEdge shares fall on new CEO appointmentMarkets Surge Amidst Economic Optimism and Tech Retreat
Blue Square X Expands Art Curation Services at Art Basel Miami
Megan Giles Cooney | Ads jar epic documentary
Naeblys SIGA Technologies' ( NASDAQ: SIGA ) stock is down 37% since my " speculative buy " recommendation in August. The recommendation followed the WHO's mpox emergency declaration and I posited that their lead asset, tecovirimat ( TPOXX ), an antiviral drug for smallpox and orthopox, may Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. This article is intended to provide informational content and should not be viewed as an exhaustive analysis of the featured company. It should not be interpreted as personalized investment advice with regard to "Buy/Sell/Hold/Short/Long" recommendations. The predictions and opinions presented are based on the author's analysis and reflect a probabilistic approach, not absolute certainty. Efforts have been made to ensure the information's accuracy, but inadvertent errors may occur. Readers are advised to independently verify the information and conduct their own research. Investing in stocks involves inherent volatility, risk, and speculative elements. Before making any investment decisions, it is crucial for readers to conduct thorough research and assess their financial circumstances. The author is not liable for any financial losses incurred as a result of using or relying on the content of this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
None